201 related articles for article (PubMed ID: 10973799)
1. Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors.
Bahrenberg G; Brauers A; Joost HG; Jakse G
Biochem Biophys Res Commun; 2000 Sep; 275(3):783-8. PubMed ID: 10973799
[TBL] [Abstract][Full Text] [Related]
2. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma.
Amara N; Palapattu GS; Schrage M; Gu Z; Thomas GV; Dorey F; Said J; Reiter RE
Cancer Res; 2001 Jun; 61(12):4660-5. PubMed ID: 11406532
[TBL] [Abstract][Full Text] [Related]
3. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.
Reiter RE; Gu Z; Watabe T; Thomas G; Szigeti K; Davis E; Wahl M; Nisitani S; Yamashiro J; Le Beau MM; Loda M; Witte ON
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1735-40. PubMed ID: 9465086
[TBL] [Abstract][Full Text] [Related]
4. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma.
Argani P; Rosty C; Reiter RE; Wilentz RE; Murugesan SR; Leach SD; Ryu B; Skinner HG; Goggins M; Jaffee EM; Yeo CJ; Cameron JL; Kern SE; Hruban RH
Cancer Res; 2001 Jun; 61(11):4320-4. PubMed ID: 11389052
[TBL] [Abstract][Full Text] [Related]
5. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
Zhigang Z; Wenlu S
Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
[TBL] [Abstract][Full Text] [Related]
6. PSCA expression is regulated by phorbol ester and cell adhesion in the bladder carcinoma cell line RT112.
Bahrenberg G; Brauers A; Joost HG; Jakse G
Cancer Lett; 2001 Jul; 168(1):37-43. PubMed ID: 11368875
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma.
de Nooij-van Dalen AG; van Dongen GA; Smeets SJ; Nieuwenhuis EJ; Stigter-van Walsum M; Snow GB; Brakenhoff RH
Int J Cancer; 2003 Mar; 103(6):768-74. PubMed ID: 12516096
[TBL] [Abstract][Full Text] [Related]
8. Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer.
Wente MN; Jain A; Kono E; Berberat PO; Giese T; Reber HA; Friess H; Büchler MW; Reiter RE; Hines OJ
Pancreas; 2005 Aug; 31(2):119-25. PubMed ID: 16024997
[TBL] [Abstract][Full Text] [Related]
9. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.
Dannull J; Diener PA; Prikler L; Fürstenberger G; Cerny T; Schmid U; Ackermann DK; Groettrup M
Cancer Res; 2000 Oct; 60(19):5522-8. PubMed ID: 11034097
[TBL] [Abstract][Full Text] [Related]
10. Prostate stem cell antigen: a Jekyll and Hyde molecule?
Saeki N; Gu J; Yoshida T; Wu X
Clin Cancer Res; 2010 Jul; 16(14):3533-8. PubMed ID: 20501618
[TBL] [Abstract][Full Text] [Related]
11. Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer.
Fawzy MS; Mohamed RH; Elfayoumi AR
Med Oncol; 2015 Mar; 32(3):74. PubMed ID: 25698533
[TBL] [Abstract][Full Text] [Related]
12. Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer.
Reiter RE; Sato I; Thomas G; Qian J; Gu Z; Watabe T; Loda M; Jenkins RB
Genes Chromosomes Cancer; 2000 Jan; 27(1):95-103. PubMed ID: 10564591
[TBL] [Abstract][Full Text] [Related]
13. Growth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways.
Marra E; Uva P; Viti V; Simonelli V; Dogliotti E; De Rinaldis E; Lahm A; La Monica N; Nicosia A; Ciliberto G; Palombo F
BMC Cancer; 2010 Apr; 10():129. PubMed ID: 20374648
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population.
Wang S; Tang J; Wang M; Yuan L; Zhang Z
Carcinogenesis; 2010 Apr; 31(4):621-4. PubMed ID: 20083643
[TBL] [Abstract][Full Text] [Related]
15. Prostate stem cell antigen is overexpressed in prostate cancer metastases.
Lam JS; Yamashiro J; Shintaku IP; Vessella RL; Jenkins RB; Horvath S; Said JW; Reiter RE
Clin Cancer Res; 2005 Apr; 11(7):2591-6. PubMed ID: 15814638
[TBL] [Abstract][Full Text] [Related]
16. Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk.
Fu YP; Kohaar I; Rothman N; Earl J; Figueroa JD; Ye Y; Malats N; Tang W; Liu L; Garcia-Closas M; Muchmore B; Chatterjee N; Tarway M; Kogevinas M; Porter-Gill P; Baris D; Mumy A; Albanes D; Purdue MP; Hutchinson A; Carrato A; Tardón A; Serra C; García-Closas R; Lloreta J; Johnson A; Schwenn M; Karagas MR; Schned A; Diver WR; Gapstur SM; Thun MJ; Virtamo J; Chanock SJ; Fraumeni JF; Silverman DT; Wu X; Real FX; Prokunina-Olsson L
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4974-9. PubMed ID: 22416122
[TBL] [Abstract][Full Text] [Related]
17. The
Wang XF; Liu DL; Geng L
Genet Test Mol Biomarkers; 2023 Feb; 27(2):44-55. PubMed ID: 36853840
[No Abstract] [Full Text] [Related]
18. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.
Gu Z; Thomas G; Yamashiro J; Shintaku IP; Dorey F; Raitano A; Witte ON; Said JW; Loda M; Reiter RE
Oncogene; 2000 Mar; 19(10):1288-96. PubMed ID: 10713670
[TBL] [Abstract][Full Text] [Related]
19. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
Zhigang Z; Wenlv S
Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
[TBL] [Abstract][Full Text] [Related]
20. Prostate stem cell antigen and cancer risk, mechanisms and therapeutic implications.
Yang X; Guo Z; Liu Y; Si T; Yu H; Li B; Tian W
Expert Rev Anticancer Ther; 2014 Jan; 14(1):31-7. PubMed ID: 24308679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
